| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research articles |
UMR 145, Institut de Recherche pour le Développement, Montpellier, France; Unité INSERM 593 (ex-330), ISPED, Université Victor Segalen Bordeaux 2, Bordeaux, France; Unité de Biostatistiques, INSERM EMI 03 38, Bordeaux, France; Programme PACCI, Abidjan, Côte d'Ivoire; Programme PACCI, Abidjan, Côte d'Ivoire; Unité de Biostatistiques, INSERM EMI 03 38, Bordeaux, France; Programme PACCI, Abidjan, Côte d'Ivoire; CeDRes, CHU de Treichville, Abidjan, Côte d'Ivoire; Unité INSERM 593 (ex-330), ISPED, Université Victor Segalen Bordeaux 2, Bordeaux, France; Service de Gynécologie-obstétrique, CHU de Yopougon, Abidjan, Côte d'Ivoire; Unité INSERM 593 (ex-330), ISPED, Université Victor Segalen Bordeaux 2, Bordeaux, France
Antenatal HIV seroprevalence surveys are important tools to understand the extent of the HIV epidemic in Africa. The main objective is to describe HIV prevalence trends from 1995–2002 in pregnant women consulting antenatal clinics in Abidjan, Côte d'Ivoire. We proposed HIV test to pregnant women consulting antenatal clinics in Abidjan from 1995–2002 in a programme of prevention of mother-to-child transmission of HIV. Yearly prevalence was estimated. Overall, 36,442 women were tested. Prevalence decreased from 14–15% in 1995–96 to 11% in 2002. The prevalence among 18–22-year-old women dropped from 15% in 1995 to 8% in 2002, while for older women it increased slightly, or remained stable from 1995–1999 and decreased thereafter.
HIV prevalence among women consulting antenatal clinics has been decreasing overall. This is the first such report among pregnant women in Abidjan, probably the result of different phenomena: ageing of the epidemic and behaviour changes (disease awareness and prevention campaigns).
Key Words: HIV INFECTION COTE D'IVOIRE PREVALENCE PREGNANT WOMEN
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?